In addition, IGF-1 enhances IRS-2 phosphorylation to a greater degree than IRS-1 in metastatic mammary tumor cells, and knockdown of IRS-2 expression reduces IGF-mediated motility in vitro [125]. Here, IRS2 is linked to breast cancer.